期刊文献+

ATP生物荧光检测法在观察产房工作人员手卫生与产后医院感染关系的分析 被引量:19

Effect of ATP bioluminescence assay on observation of relationship between hand hygiene of delivery room staff and postpartum nosocomial infection
原文传递
导出
摘要 目的探讨分析ATP生物荧光检测法在观察产房工作人员手卫生与产后医院感染关系的影响。方法选取医院的产房医师、护士、进修实习人员共90例作为研究对象,采用自身对照的方法,分为对照组与研究组。对照组实施基线调查,对医务人员的手卫生知识掌握情况以及不同工作时刻的手卫生依从性进行监测评估,研究组施以ATP生物荧光检测法干预措施,观察比较两组医务人员干预前后的主动洗手率、手卫生合格率以及干预前后院内的感染情况。结果干预前,医务人员在不同工作时刻主动洗手率与手卫生合格率无明显差异;干预后观察组主动洗手率及手卫生合格率均显著高于对照组,且两组比较差异均有统计学意义(P<0.05);干预前观察组与对照组在院内发生感染率比较无统计学意义;干预后观察组院内发生感染率显著低于对照组,两组比较差异有统计学意义(P<0.05)。结论 ATP生物荧光检测法在观察产房工作人员手卫生时进行现场的监测反馈,能显著提高医务人员的手卫生依从性与合格率,降低产后医院感染率,值得临床上推广应用。 OBJECTIVE To explore the effect of ATP bioluminescence assay on observation of the relationship between hand hygiene of delivery room staff and postpartum nosocomial infection.METHODS Totally 90 doctors,nurses and interns of delivery room were recruited as the study objects and divided into the control group and the study group by the self-controlled method.The baseline survey was conducted in the control group,the acquisition of knowledge of hand hygiene and the hand hygiene compliance at different time points were monitored and evaluated;the ATP bioluminescence assay was performed in the stud group.The rate of initiative hand washing,qualified rate of hand hygiene and incidence of nosocomial infection were observed and compared between the two groups of health care workers before and after the intervention.RESULTS Before the intervention,there were no significant differences in the rate of initiative hand washing and qualified rate of hand hygiene among the health care workers at the different time points;the rate of initiative hand washing and qualified rate of hand hygiene were significantly higher in the observation group than in the control group after the intervention(P〈0.05);there was no significant difference in the incidence of nosocomial infection between the observation group and the control group before the intervention;the incidence of nosocomial infection of the observation group was significantly lower than that of the control group after the intervention(P〈0.05).CONCLUSIONThe onsite monitoring and feedback of hand hygiene of the delivery room staff based on the ATP bioluminescence assay may effectively raise the hand hygiene compliance and qualified rate of hand hygiene of the health care workers and reduce the incidence of postpartum nosocomial infection,and it is worthy to be promoted in the hospital.
作者 朱艳萍 刘素珍 张甜 欧阳琳 李文 ZHU Yan-ping;LIU Su-zhen;ZHANG Tian;OUYANG Lin;LI Wen(People's Hospital of Xingguo County,Ganzhou City,Ganzhou,Jiangxi 342400,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2018年第22期3509-3512,共4页 Chinese Journal of Nosocomiology
基金 江苏省卫生计生委科技计划基金资助项目(20155369)
关键词 ATP生物荧光检测法 产房 依从性 手卫生 产后感染关系 ATP bioluminescence assay Delivery room Compliance Hand hygiene Postpartum nosocomial in-fection
  • 相关文献

参考文献8

二级参考文献57

  • 1施雁,华萍,毛雅芬,万祎洁.护理人力资源与护理质量相关性分析[J].中国医院,2005,9(5):61-63. 被引量:57
  • 2田海梅,石晓燕,傅军,曹冬艳,张凯,吴令英,王金万,张伟.ATP抗肿瘤药物敏感性检测技术与卵巢癌临床治疗的相关性研究[J].中华肿瘤杂志,2005,27(5):296-298. 被引量:17
  • 3韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量:631
  • 4中华人民共和国卫生部.医务人员手卫生规范[S].2009-04-01.
  • 5Sevin BU,Peng ZL,Perras JP,et al.Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.Gynecol Oncol,1988,31:191-204.
  • 6Cree IA,Kuroacher CM,Lamont A,et al.A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.Anticancer Drugs,2007,18:1093-1101.
  • 7Neale MH,Lamont A,Hindley A,et al.The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma.Anticancer Drugs,2000,11:865-871.
  • 8Gordon AN,Fleagle JT,Guthrie D,et al.Recurrent epithelial ovarian carcinoma:a randomized phase Ⅲ study of pegylated liposomal doxorubicin versus topotecan.J Clin Oncol,2001,19:3312-3322.
  • 9Ferrandina G,Ludovisi M,Lorusso D,et al.Phase Ⅲ trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.J Clin Oncol,2008,26:890-896.
  • 10Markman M,Hall J,Spitz D,et al.Phase Ⅱ trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer.J Clin Oncol,2002,20:2365-2369.

共引文献80

同被引文献179

引证文献19

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部